Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001209191-23-003999

CMO,SVP,Head-Res&Drug acquired 14,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shetzline Michael CMO,SVP,Head-Res&Drug 2023-01-17 Grant or award +14,663 280,908 D: show line 1 in the form
Loading xslF345X03/doc4.xml…